Cargando…
Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy
Liver cancer is the fourth leading cause of cancer-related death worldwide. Hepatocellular carcinoma (HCC) accounts for about 85%-90% of all primary liver malignancies. However, only 20-30% of HCC patients are eligible for curative therapy mainly due to the lack of early-detection strategies, highli...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851237/ https://www.ncbi.nlm.nih.gov/pubmed/35186756 http://dx.doi.org/10.3389/fonc.2022.822449 |